Drug intelligence / Profile preview

C4BPA recombinant protein

Development stage
Preclinical
Modality
Recombinant Proteins and Enzymes
01

Overview

C4BPA (C4b-binding protein alpha chain) is a protein identified as a key mediator of muscle degeneration in Duchenne muscular dystrophy (DMD). It is secreted at elevated levels by pathological fibroadipogenic precursor cells (FAPs) within the dystrophic muscle environment. Recombinant C4BPA is used in research to demonstrate its potent anti-myogenic effects, which include the impairment of myotube formation, downregulation of myogenic markers, and reduction of contractile function in muscle models. Because silencing or neutralizing C4BPA has been shown to restore myogenic capacity and improve muscle differentiation, it is currently being investigated as a novel therapeutic target to preserve muscle regeneration and mitigate the fibrotic progression associated with DMD.

Other names
C4b-binding protein alpha chainC-4b-binding protein alpha chainC 4b-binding protein alpha chainC4BP alphaC-4BP alphaC 4BP alphaC4BPAC-4BPAC 4BPArecombinant C4BPA
02

Targets

SAP (Pentraxin 2)C4B (Complement component 4B)C3b (Complement Component 3b)

Beyond the preview

Go deeper on C4BPA recombinant protein.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on C4BPA recombinant protein.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call